◀ Back to NFKB1

NFKB1 — PLG

Text-mined interactions from Literome

Yoshizaki et al., Histol Histopathol 2002 (Carcinoma...) : LMP-1 down-regulates expression of E-cadherin, induces matrix metalloproteinase-9 and urokinase type-plasminogen activator through activation of NF-kappaB and AP-1, and enhances cell motility via ets-1 activation
Syrovets et al., Thromb Haemost 2002 (Inflammation) : Ciglitazone activates PPAR gamma as shown by a novel surface plasmon resonance analysis and inhibits the plasmin induced activation of NF-kappa B and AP-1
Mahabeleshwar et al., J Biol Chem 2003 (Anoxia...) : Luciferase reporter gene assay indicated that Lck induces NFkappaB dependent urokinase type plasminogen activator ( uPA ) promoter activity in presence of H/R
Min et al., Biochem Biophys Res Commun 2003 : Furthermore, plasminogen stimulated CREB and NF-kappaB DNA binding activity, and this activation was also reduced by trolox and NAC
Iwasaki et al., Atherosclerosis 2008 (Hyperglycemia) : High glucose induces plasminogen activator inhibitor-1 expression through Rho/Rho-kinase mediated NF-kappaB activation in bovine aortic endothelial cells
Zare et al., J Leukoc Biol 2008 : In contrast, Plg production did not require NF-kappaB , was only partly down-regulated by p38 MAPK inhibitor, and was efficiently inhibited by insulin, indicating a different mechanism for its induction
Ng et al., J Biol Chem 1994 : Although tumor necrosis factor (TNF) and interleukin-1 ( IL ) induce the expression of the IL-8, TNF stimulated gene 6, and plasminogen activation inhibitor-2 genes and the activation of NF-kappa B with nearly identical kinetics, the two cytokines differ significantly in the induction of the IL-6 gene in all primary fibroblasts tested